Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Axitinib Implant) in Subjects With Neovascular Age- Related Macular Degeneration (NCT06495918)

🧪 Interventions in This Study

• OTX-TKI (DRUG)
• Aflibercept (DRUG)
• Aflibercept (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (97 Sites)

Showing the first 25 of 97 sites.

• Associated Retina Consultant — Gilbert, Arizona
• Associated Retina Consultants, Ltd. — Phoenix, Arizona
• Retinal Research Institute, LLC — Phoenix, Arizona
• Retina Macula Institute of Arizona — Scottsdale, Arizona
• California Retina Consultants — Bakersfield, California
• The Retina Partners — Encino, California
• Retina Consultants of Orange County — Fullerton, California
• Atlantis Eyecare — Huntington Beach, California
• Salehi Retina Institute, Inc., dba Retina Associates of Southern California — Huntington Beach, California
• Kaiser Permanente Division of Research — Oakland, California
• California Retina Consultants — Oxnard, California
• Stanford Health Care - Byers Eye Institute — Palo Alto, California
• Stanford University School of Medicine, Byers Eye Institute — Palo Alto, California
• California Eye Specialists Medical Group, INC — Pasadena, California
• Retinal Consultants Medical Group — Sacramento, California
• Orange County Retina Medical Group — Santa Ana, California
• California Retina Consultants — Santa Barbara, California
• Macula Retina Vitreous Research Institute — Torrance, California
• Bay Area Retina Associates — Walnut Creek, California
• Retina Consultants of Southern Colorado — Colorado Springs, Colorado
• RSC Research, LLC — Denver, Colorado
• Colorado Retina Associates — Lakewood, Colorado
• Retina Consultants, P.C — Manchester, Connecticut
• Retina Group of New England — Waterford, Connecticut
• Advanced Research LLC. — Deerfield Beach, Florida

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Neovascular Age-related Macular Degeneration

• A Phase 3b, Single-Arm Study of Aflibercept 8 mg Dosed Every 4 Weeks in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD) or Diabetic Macular Edema (DME) — Arcadia, California
• A Safety and Efficacy Study of One-time SAR402663 in Adults With Neovascular Age-related Macular Degeneration — Phoenix, Arizona
• Effect of AIV007 by Periocular Administration in Subjects with Macular Edema Secondary to Neovascular Age-related Macular Degeneration (nAMD) and Diabetic Macular Edema (DME) — Beverly Hills, California
• Home OCT-Guided Treatment Versus Treat and Extend for the Management of Neovascular AMD — Glendale, California
• Safety and Efficacy of ADVM-022 in Treatment-Experienced Patients With Neovascular Age-related Macular Degeneration [LUNA] — Phoenix, Arizona

Explore by condition: All Neovascular Age-related Macular Degeneration clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Review the official NIH record below to find the coordinating site.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.